Abstracts
Incidence Rates and Social Factors Associated with Heart Failure Related Encounters in Metropolitan Detroit, Michigan, Emergency Departments from 2018-2024.
Brian Haber, Robert Ehrman, Samantha Bauer, and Steven J. Korzeniewski
Objective: Population-level heart failure (HF) incidence and hospitalizations have increased in the past decade but there is sparse evidence on ED-related visits, particularly from densely populated urban areas in the post-pandemic era. Lack of epidemiologic data is detrimental as individuals in these areas often experience substantial social and economic stressors, which prior literature has suggested are associated with greater ED use and worse outcomes. The goal of this project was to estimate the prevalence and incidence density rates of HF-related ED visits in Metropolitan Detroit, MI, and characterize associations between measures of social stress, ED visits, and hospital admissions for HF.
Methods: Using an existing surveillance database from 5 EDs, we identified adults presenting between 12/2018-3/2024 and had home addresses that were geocoded in four catchment counties. HF was identified as the primary diagnosis by ICD-10 codes (I50.x). Prevalence and incidence density rates were calculated per 10,000 (10k) encounters, unique patients, and total population (separately) using county denominators from the 2020 U.S. Census. Trends were examined using locally weighted regression. A subset of patients had data available for repeat ED visits and ED disposition from 2023. We matched patients to zipcode-level Social Deprivation Index (SDI, range 0-100 with greater scores representing more deprivation), proportion of patients without health insurance (PWI), and mean systolic blood pressure (SBP) of patients visiting the ED, abstracted from the Wayne State Population Health Outcomes Information Exchange (PHOENIX). Social factors associated with repeat ED visits were modeled using negative binomial regression. For factors associated with admission vs. discharge, a mixed-effects logistic model with a random intercept for each patient was used. In both models, the primary predictor of interest was SDI, and an offset of ED visits per 100k patients from each zip code (also abstracted from PHOENIX) was used. Selection of final models was based on Bayesian Information Criteria.
Results: The 502,367 patients who presented during the study period accounted for 1,034,591 total encounters. There were 2,259 unique patients with EHR-documented HF resulting in estimated prevalence rates of 5.7 (95%CI 5.5-5.9) per 10K total population, 25.3 (95%CI 24.3-26.3) per 10K encounters, and 45 (95%CI 43.1-46.8) per 10k unique patients. Incidence density rates declined after 2020, but the pattern coincided with an overall reduction in ED utilization. In the 2023 cohort, complete data were available on 284 patients who accounted for 785 HF visits. Unadjusted SDI < median (95, IQR 6) was associated with increased relative risk (RR) of a repeat ED visit of 1.36 (p<0.0001). After adjusting for PWI, RR of a repeat visit for SDI was 1.12 (p=0.2) and for PWI 9.42 (p=0.0005). The same pattern was seen for odds ratio (OR) of admission: unadjusted SDI < median, OR 1.84 (p=0.01); adjusted for PWI, SDI < median OR 1.06 (p=0.8), PWI OR 8.76 (p=0.001). Other social factors assessed were not associated with repeat visits or hospital admission.
Conclusion: Overall ED use as well as the incidence density rate of HF-related ED encounters declined among metropolitan Detroit EDs from 12/2018-to-3/2024. In the unadjusted analysis, lower SDI (less deprivation) was associated with more ED re-visits and more admissions, but this effect was lost after adjusting for PWI in patients’ zip code. In fact, the effect of living in a zip code with a larger PWI had a markedly greater effect than SDI. Given that the pandemic changed how patients interact with the healthcare system (e.g., where, when, and from whom they seek care), further study is needed to elucidate the complex relationships between social stressors and ED attendance. Future research should also explore ways in which lack of health insurance can affect HF care (e.g., lack of options for outpatient follow-up). Investigations in other locations are likewise needed to confirm our findings.
Publications
2024
Salerno PRVO, Qian A, Dong W, Deo S, Nasir K, Rajagopalan S, Al-Kindi S. County-level socio-environmental factors and obesity prevalence in the United States. Diabetes Obes Metab. 2024 May;26(5):1766-1774. doi: 10.1111/dom.15488. Epub 2024 Feb 14. PMID: 38356053; PMCID: PMC11447680.
Sadeer Al-Kindi, Sanjay Rajagopalan, Pedro R.V.O. Salerno, Steven Korzeniewski, Philip Levy, Issam Motairek, Robert D. Brook,
Disparities in Excess Blood Pressure Across the U.S. Associated With Air Pollution Exceeding WHO Guidelines,
JACC: Advances,
Volume 3, Issue 7, Part 2,2024,100876,ISSN 2772-963X,
https://doi.org/10.1016/j.jacadv.2024.100876.
2023
Debbs, J., Hannawi, B., Peterson, E., Gui, H., Zeld, N., Luzum, J. A., Sabbah, H. N., Snider, J., Pinto, Y. M., Williams, L. K., & Lanfear, D. E. (2023). Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients. Journal of cardiovascular translational research, 16(6), 1343–1348. https://doi.org/10.1007/s12265-023-10397-3
Motairek I, Chen Z, Makhlouf MHE, Deo S, Salerno PRVO, Mentias A, Nasir K, Rajagopalan S, Al-Kindi SG. Mapping Geographic Proximity to Cardiologists Across the United States. Circ Cardiovasc Qual Outcomes. 2023 Oct;16(10):e010133. doi: 10.1161/CIRCOUTCOMES.123.010133. Epub 2023 Sep 12. PMID: 37698011; PMCID: PMC10592115.
Motairek I, Makhlouf MHE, Rajagopalan S, Al-Kindi S. The Exposome and Cardiovascular Health. Can J Cardiol. 2023 Sep;39(9):1191-1203. doi: 10.1016/j.cjca.2023.05.020. Epub 2023 Jun 6. PMID: 37290538; PMCID: PMC10526979.
Brook RD, Levy PD, Brook AJ, Opara IN. Community Health Workers as Key Allies in the Global Battle Against Hypertension: Current Roles and Future Possibilities. Circ Cardiovasc Qual Outcomes. 2023 Mar;16(3):e009900. doi: 10.1161/CIRCOUTCOMES.123.009900. Epub 2023 Feb 23. PMID: 36815465; PMCID: PMC11200125.
Byrd JB, Bisognano JD, Brook RD. Treating Hypertension in Patients With Orthostatic Hypotension: Benefits vs Harms in the Era of Aggressive Blood Pressure Lowering. JAMA. 2023 Oct 17;330(15):1435-1436. doi: 10.1001/jama.2023.19096. PMID: 37847283.
Kaciroti N, Jamerson KA, Brook RD. Cardiovascular Protection Beyond Blood Pressure-Lowering Redux: The ACCOMPLISH trial. Hypertension. 2024 Mar;81(3):e13-e15. doi: 10.1161/HYPERTENSIONAHA.123.22425. Epub 2024 Feb 14. PMID: 38354269; PMCID: PMC10868869.
Golbus JR, Gosch K, Birmingham MC, Butler J, Lingvay I, Lanfear DE, Abbate A, Kosiborod ML, Damaraju CV, Januzzi JL Jr, Spertus J, Nallamothu BK. Association Between Wearable Device Measured Activity and Patient-Reported Outcomes for Heart Failure. JACC Heart Fail. 2023 Nov;11(11):1521-1530. doi: 10.1016/j.jchf.2023.05.033. Epub 2023 Jul 26. PMID: 37498273.
Lanfear DE, Njoroge JN, Adams KF, Anand I, Fang JC, Ramires F, Sliwa-Hahnle K, Badat A, Burgess L, Gorodeski EZ, Williams C, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon S, Miao ZM, Claggett BL, Heitner SB, Kupfer S, Malik FI, Teerlink JR. Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF. JACC Heart Fail. 2023 May;11(5):569-579. doi: 10.1016/j.jchf.2022.11.021. Epub 2023 Feb 1. PMID: 36881396.
Mamic P, Lanfear DE. Gut Microbiome in Cardiovascular Disease and Heart Failure: Seeing the Iceberg Below Its Surface. JACC Heart Fail. 2023 Jul;11(7):822-824. doi: 10.1016/j.jchf.2023.05.011. PMID: 37407156.
Felker GM, Solomon SD, Metra M, Mcmurray JJV, Diaz R, Claggett B, Lanfear DE, Vandekerckhove H, Biering-Sørensen T, Lopes RD, Arias-Mendoza A, Momomura SI, Corbalan R, Ramires FJA, Zannad F, Heitner SB, Divanji PH, Kupfer S, Malik FI, Teerlink JR. Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study. J Card Fail. 2024 Jun;30(6):755-763. doi: 10.1016/j.cardfail.2023.11.021. Epub 2024 Jan 11. PMID: 38215932.
Mohebi R, Jones PG, Spertus JA, Lingvay I, Lanfear DE, Gosch KL, Birmingham M, Kosiborod MN, Butler J, Januzzi JL Jr. Early Longitudinal Change in Heart Failure Health Status Following Initiation of Canagliflozin. JACC Heart Fail. 2024 Apr;12(4):711-718. doi: 10.1016/j.jchf.2024.01.005. Epub 2024 Feb 21. PMID: 38385941.
Diamond JE, Kaltenbach LA, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Butler J, Allen LA, Lanfear DE, Thibodeau JT, Granger CB, Hernandez AF, Ariely D, DeVore AD. Access to Mobile Health Interventions Among Patients Hospitalized With Heart Failure: Insights Into the Digital Divide From the CONNECT-HF mHealth Substudy. Circ Heart Fail. 2024 Feb;17(2):e011140. doi: 10.1161/CIRCHEARTFAILURE.123.011140. Epub 2024 Jan 11. PMID: 38205653.
Luzum JA, Campos-Staffico AM, Li J, She R, Gui H, Peterson EL, Liu B, Sabbah HN, Donahue MP, Kraus WE, Williams LK, Lanfear DE. Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction. Genes (Basel). 2023 Oct 28;14(11):2019. doi: 10.3390/genes14112019. PMID: 38002962; PMCID: PMC10671316.
Debbs J, Hannawi B, Peterson E, Gui H, Zeld N, Luzum JA, Sabbah HN, Snider J, Pinto YM, Williams LK, Lanfear DE. Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients. J Cardiovasc Transl Res. 2023 Dec;16(6):1343-1348. doi: 10.1007/s12265-023-10397-3. Epub 2023 May 16. PMID: 37191882; PMCID: PMC10651796.
Lanfear DE, Luzum JA, She R, Li J, Sabbah HN, Zeld N, Liu B, Peterson E, Keoki Williams L. Validation of a Polygenic Score for Beta-Blocker Survival Benefit in Patients With Heart Failure Using the United Kingdom Biobank. Circ Genom Precis Med. 2023 Apr;16(2):e003835. doi: 10.1161/CIRCGEN.121.003835. Epub 2023 Mar 3. PMID: 36866666; PMCID: PMC10121886.
Milioglou I, Motairek I, Deo S, Ramani R, Neeland IJ, Rajagopalan S, Al-Kindi SG. Time-Varying Cardiovascular Outcomes of Sodium-Glucose Cotransporter Inhibitors in Patients With Type 2 Diabetes: A Post Hoc Analysis of Pivotal Trials Using Restricted Mean Survival Time. Circ Cardiovasc Qual Outcomes. 2023 Mar;16(3):e009491. doi: 10.1161/CIRCOUTCOMES.122.009491. Epub 2023 Mar 1. PMID: 36856041.
Deo SV, Al-Kindi S, Motairek I, McAllister D, Shah ASV, Elgudin YE, Gorodeski EZ, Virani S, Petrie MC, Rajagopalan S, Sattar N. Impact of Residential Social Deprivation on Prediction of Heart Failure in Patients With Type 2 Diabetes: External Validation and Recalibration of the WATCH-DM Score Using Real World Data. Circ Cardiovasc Qual Outcomes. 2024 Mar;17(3):e010166. doi: 10.1161/CIRCOUTCOMES.123.010166. Epub 2024 Feb 8. PMID: 38328913; PMCID: PMC11093755.
Chen Z, Dazard JE, Khalifa Y, Motairek I, Al-Kindi S, Rajagopalan S. Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence. Eur Heart J. 2024 May 7;45(17):1540-1549. doi: 10.1093/eurheartj/ehae158. PMID: 38544295; PMCID: PMC11075932.
Salerno PRVO, Motairek I, Dong W, Nasir K, Fotedar N, Omran SS, Ganatra S, Hahad O, Deo SV, Rajagopalan S, Al-Kindi SG. County-Level Socio-Environmental Factors Associated With Stroke Mortality in the United States: A Cross-Sectional Study. Angiology. 2024 Apr 3:33197241244814. doi: 10.1177/00033197241244814. Epub ahead of print. PMID: 38569060.
D'Oro A, Patel DH, Wass S, Dolber T, Nasir K, Dobre M, Rahman M, Al-Kindi S. Depression and incident cardiovascular disease among patients with chronic kidney disease. Int J Cardiol Cardiovasc Risk Prev. 2023 Jul 18;18:200199. doi: 10.1016/j.ijcrp.2023.200199. PMID: 37534371; PMCID: PMC10391655.
Dong T, Harris K, Freedman D, Janus S, Griggs S, Iyer Y, Nasir K, Neeland IJ, Rajagopalan S, Al-Kindi SG. Food insecurity and atherosclerotic cardiovascular disease risk in adults with diabetes. Nutrition. 2023 Feb;106:111865. doi: 10.1016/j.nut.2022.111865. Epub 2022 Oct 14. PMID: 36473415; PMCID: PMC9851285.
Al-Kindi SG, Brook RD, Dobre M, Rahman M, Wright JT, Rajagopalan S. Ambient Air Pollution and Pulse Wave Velocity in Patients With Hypertension Treated With Intensive Versus Standard Blood Pressure Control. Hypertension. 2022 Dec;79(12):e144-e146. doi: 10.1161/HYPERTENSIONAHA.122.19779. Epub 2022 Sep 29. PMID: 36176038; PMCID: PMC9649852.
Motairek I, Chen Z, Makhlouf MHE, Deo S, Salerno PRVO, Mentias A, Nasir K, Rajagopalan S, Al-Kindi SG. Mapping Geographic Proximity to Cardiologists Across the United States. Circ Cardiovasc Qual Outcomes. 2023 Oct;16(10):e010133. doi: 10.1161/CIRCOUTCOMES.123.010133. Epub 2023 Sep 12. PMID: 37698011; PMCID: PMC10592115.
Motairek I, Dong W, Salerno PR, Janus SE, Ganatra S, Chen Z, Guha A, Makhlouf MH, Hassani NS, Rajagopalan S, Al-Kindi SG. Geographical Patterns and Risk Factor Association of Cardio-Oncology Mortality in the United States. Am J Cardiol. 2023 Aug 15;201:150-157. doi: 10.1016/j.amjcard.2023.06.037. Epub 2023 Jun 27. PMID: 37385168; PMCID: PMC10529631.
Bevan G, Pandey A, Griggs S, Dalton JE, Zidar D, Patel S, Khan SU, Nasir K, Rajagopalan S, Al-Kindi S. Neighborhood-level Social Vulnerability and Prevalence of Cardiovascular Risk Factors and Coronary Heart Disease. Curr Probl Cardiol. 2023 Aug;48(8):101182. doi: 10.1016/j.cpcardiol.2022.101182. Epub 2022 Mar 27. PMID: 35354074; PMCID: PMC9875801.
Gupta K, Spertus JA, Birmingham M, Gosch KL, Husain M, Kitzman DW, Pitt B, Shah SJ, Januzzi JL, Lingvay I, Butler J, Kosiborod M, Lanfear DE. Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials. Circulation. 2023 Jul 18;148(3):220-228. doi: 10.1161/CIRCULATIONAHA.122.063263. Epub 2023 May 16. PMID: 37191040; PMCID: PMC10523916.
Al-Kindi S, Motairek I, Kreatsoulas C, Wright JT Jr, Dobre M, Rahman M, Rajagopalan S. Historical Neighborhood Redlining and Cardiovascular Risk in Patients With Chronic Kidney Disease. Circulation. 2023 Jul 18;148(3):280-282. doi: 10.1161/CIRCULATIONAHA.123.064215. Epub 2023 Jul 17. PMID: 37459405; PMCID: PMC10361625.
Byrd JB, Bisognano JD, Brook RD. Treating Hypertension in Patients With Orthostatic Hypotension: Benefits vs Harms in the Era of Aggressive Blood Pressure Lowering. JAMA. 2023;330(15):1435–1436. doi:10.1001/jama.2023.19096
Makhlouf MHE, Motairek I, Chen Z, Nasir K, Deo SV, Rajagopalan S, Al-Kindi SG. Neighborhood Walkability and Cardiovascular Risk in the United States. Curr Probl Cardiol. 2023 Mar;48(3):101533. doi: 10.1016/j.cpcardiol.2022.101533. Epub 2022 Dec 5. PMID: 36481391; PMCID: PMC9892210.
Bevan G, Pandey A, Griggs S, Dalton JE, Zidar D, Patel S, Khan SU, Nasir K, Rajagopalan S, Al-Kindi S. Neighborhood-level Social Vulnerability and Prevalence of Cardiovascular Risk Factors and Coronary Heart Disease. Curr Probl Cardiol. 2023 Aug;48(8):101182. doi: 10.1016/j.cpcardiol.2022.101182. Epub 2022 Mar 27. PMID: 35354074; PMCID: PMC9875801.
2022
Brook RD, Levy PD, Brook AJ, Opara IN. Community Health Workers as Key Allies in the Global Battle against Hypertension: Current Roles and Future Possibilities. Circ Qual Cardiovasc Outcomes Originally published23 Feb 2023
Issam Motaireka, Zhuo Chena, Mohamed H. E. Makhloufa, Sanjay Rajagopalan, Sadeer Al-Kindi: Historical Neighborhood redlining and contemporary environmental racism Published online: 10 Dec 2022
Motairek I, Makhlouf MH, Rajagopalan S, Al-Kindi S. The Exposome and Cardiovascular Health. Canadian Journal of Cardiology. 2023 Jun 6.
Motairek I, Al-Kindi S. Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes. Endocrinology and Metabolism Clinics. 2023 Mar 1;52(1):135-47.
Dong T, Harris K, Freedman D, Janus S, Griggs S, Iyer Y, Nasir K, Neeland IJ, Rajagopalan S, Al-Kindi SG. Food insecurity and atherosclerotic cardiovascular disease risk in adults with diabetes. Nutrition. 2023 Feb 1;106:111865.
Dong W, Motairek I, Nasir K, Chen Z, Kim U, Khalifa Y, Freedman D, Griggs S, Rajagopalan S, Al-Kindi SG. Risk factors and geographic disparities in premature cardiovascular mortality in US counties: a machine learning approach. Scientific Reports. 2023 Feb 20;13(1):2978.
Lobo TN, Motairek I, Perzynski A, Al-Kindi S. Health Equity Metrics for the US News and World Report Honor Roll Hospitals. Journal of General Internal Medicine. 2023 Mar 21:1-3.
Motairek I, Deo SV, Elgudin Y, McAllister DA, Brook RD, Chen Z, Su J, Rao SV, Rajagopalan S, Al-Kindi S. Particulate matter air pollution and long-term outcomes in patients undergoing percutaneous coronary intervention. JACC: Advances. 2023 May 1;2(3):100285.
Motairek I, Rajagopalan S, Al-Kindi S. The “Heart” of Environmental Justice. American Journal of Cardiology. 2023 Feb 15;189:148-9.
Al-Kindi S. Leveraging Geospatial Data Science to Uncover Novel Environmental Predictors of Cardiovascular Disease. JACC: Advances. 2023 Jun 7.
Motairek I, Sharara J, Makhlouf MH, Dobre M, Rahman M, Rajagopalan S, Al-Kindi S. Association Between Particulate Matter Pollution and CKD Mortality by Social Deprivation. American Journal of Kidney Diseases. 2023 Apr 1;81(4):497-9.
Khraishah H, Ganatra S, Al-Kindi SG. Climate Change, Environmental Pollution, and the Role of Cardiologists of the Future. Journal of the American College of Cardiology. 2023 Mar 21;81(11):1127-32.
Milioglou I, Motairek I, Deo S, Ramani R, Neeland IJ, Rajagopalan S, Al-Kindi SG. Time-Varying Cardiovascular Outcomes of Sodium-Glucose Cotransporter Inhibitors in Patients With Type 2 Diabetes: A Post Hoc Analysis of Pivotal Trials Using Restricted Mean Survival Time. Circulation: Cardiovascular Quality and Outcomes. 2023 Mar;16(3):e009491.
Motairek IK, Dong W, Salerno PRVO, Janus SE, Ganatra S, Chen Z, Guha A, Makhlouf MHE, Hassani NS, Rajagopalan SR, Al-Kindi SG. Geographical Variation and Risk Factor Association of Cardio-Oncology Mortality in the United States. Am Jour Cardiol.
Al-Kindi SG, Paneni F, Brook RD, Rajagopalan S. Residual Environmental Risk in Patients with Cardiovascular Disease: An Overlooked Paradigm. Eur Heart Jour.
Deo SV, Motairek IK, Nasir K, Mentias A, Elgudin Y, Virani S, Rajagopalan S, Al-Kindi SG. Association between Historical Neighborhood Redlining and Cardiovascular Outcomes among U.S. Veterans with Atherosclerotic Cardiovascular Diseases. JAMA Network Open [in press]
Al-Kindi SG, Motairek I, Kreatsoulas C, Wright Jr J, Dobre M, Rahman M, Rajagopalan S. Historical Neighborhood Redlining and Cardiovascular Risk in Patients with Chronic Kidney Disease. Circulation [in press].
Brook RD, Motairek IK, Rajagopalan SR, Al-Kindi SG. Excess Global Blood Pressure Associated with Fine Particulate Matter Air Pollution Levels Exceeding World Health Organization Guidelines. Journal of the American Heart Association. 2023 Apr 18;12(8):e029206
Kashvi Gupta, John A Spertus, Mary Birmingham, Kensey L Gosch, Mansoor Husain, Dalane W Kitzman, Bertram Pitt, Sanjiv J Shah, James L Januzzi, Ildiko Lingvay, Javed Butler, Mikhail Kosiborod, David E Lanfear; Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials; Circulation 2023 May 16.doi: 10.1161/CIRCULATIONAHA.122.063263. Online ahead of print PMID: 37191040 (NIHMS1891296)
Joseph Debbs, Bashar Hannawi, Edward Peterson, Hongsheng Gui, Nicole Zeld, Jasmine A. Luzum, Hani N. Sabbah, James Snider, Yigal M. Pinto, L. Keoki Williams & David E. Lanfear; Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients; J Cardiovasc Transl Res. 2023 May 16.doi: 10.1007/s12265-023-10397-3. Online ahead of print. PMID: 37191882 (NIHMS1921225)
2021
Brook RD, Dawood K, Foster B, Foust RM, Gaughan C, Kurian P, Reed B, Jones AL, Vernon B, Levy PD. Utilizing Mobile Health Units for Mass Hypertension Screening in Socially Vulnerable Communities across Detroit; Hypertension2022 Jun;79(6):e106-e108.doi: 10.1161/HYPERTENSIONAHA.122.19088. Epub 2022 Mar 16. PMID: 35291803
Brook RD, Scirica BM, Levy PD. “The doctor is out”: New tactics and soldiers for our losing battle against hypertension. Circulation2022 May 31;145(22):1629-1631. doi:10.1161/CIRCULATIONAHA.122.059674. Epub 2022 May31. PMID: 35639852
Motairek I, Chen Z, Makhlouf MH, Rajagopalan S, Al-Kindi S. Historical neighborhood redlining and contemporary environmental racism. Local Environment. 2022 Dec 10:1-1.
Al-Kindi S, Tashtish N, Rashid I, Sullivan C, Neeland IJ, Robinson M, Gross EM, Shaw L, Cainzos-Achirica M, Nasir K, Kreatsoulas C. Impact of low/no-charge coronary artery calcium scoring on statin eligibility and outcomes in women: The CLARIFY study. American Journal of Preventive Cardiology. 2022 Dec 1;12:100392.
Motairek IK, Al-Kindi SG. Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes. Endocrinology and Metabolism Clinics of North America 2022 Endocrinol Metab Clin North Am. 2023 Mar;52(1):135-147. doi:10.1016/j.ecl. 2022.07.002. Epub 2022 Nov 18.https://doi.org/10.1016/j.ecl.2022.07.002
Bevan G, Pandey A, Griggs S, Dalton JE, Zidar DA, Patel S, Khan SU, Nasir K, Rajagopalan S, Al-Kindi S. Neighborhood-Level Social Vulnerability and Prevalence of Cardiovascular Risk Factors and Coronary Heart Disease. Curr Prob Cardiol. 2022 Mar 27;101182 https://doi.org/10.1016/j.cpcardiol.2022.101182
Motairek IK, Sharara J, Makhlouf ME, Dobre M, Rahman M, Rajagopalan SR, Al-Kindi SG. Association Between Particulate Matter Pollution and CKD Mortality by Social Deprivation November 14, 2022 DOI:https://doi.org/10.1053/j.ajkd.2022.09.015
Al-Kindi SG, Brook RD, Dobre M, Rahman M, Wright JT, Rajagopalan S. Ambient Air Pollution and Pulse Wave Velocity in Patients With Hypertension Treated With Intensive Versus Standard Blood Pressure Control. Hypertension. 2022 Dec;79(12):e144-6.
Bevan G, Pandey A, Griggs S, Dalton JE, Zidar D, Patel S, Khan SU, Nasir K, Rajagopalan S, Al-Kindi S. Neighborhood-level social vulnerability and prevalence of cardiovascular risk factors and coronary heart disease. Current problems in cardiology. 2022 Mar 27:101182.
Makhlouf MH, Motairek I, Chen Z, Nasir K, Deo SV, Rajagopalan S, Al-Kindi SG. Neighborhood Walkability and Cardiovascular Risk in the United States. Current Problems in Cardiology. 2022 Dec 5:101533.
David E. Lanfear, Nosheen Reza. Myosin-Related Dilated Cardiomyopathy: Another Elephant Emerges From Darkness; https://www.sciencedirect.com/journal/journal-of-the-american-college-of-cardiology PMID: 36202535. Volume 80, Issue 15, 11 October 2022, Pages 1462-1464
Presentations
Past
American Heart Association Meeting Nov 11-13, 2023 Philadelphia PA
Phillip Levy, Detroit, MI
WAYNE STATE UNIVERSITY
Detroit, MI, United States
Community Health Workers: Extending the Clinic to the Community
Nov. 11, 2023, 10:21 AM - 10:33 AM
Phillip Levy, Detroit, MI
Driving the Van: Challenges and Victories of a Mobile Health Unit
Nov. 11, 2023, 4:00 PM - 4:12 PM
Phillip Levy, Detroit, MI
WE SPARK Health Institute 2023 Health Research Conference
"Achieving Better Health One Population at a Time”
November 2023; Windsor, Canada
American College of Cardiology Quality Summit
October 2023; Orlando, Florida
"Using the Chest Pain Guidelines to Increase Patient
Throughput and Decrease Cost of Care"
"Cardiovascular Disease Prevention at the Population Level"
Mobile Healthcare Association’s 19th Annual Mobile Health Clinics Conference
"Building an Equitable and Sustainable Mobile Health
Outreach Program"
September 2023; Pittsburgh, Pennsylvania
ACC Industry Advisory Forum July 2023
Diversity, Equity & Inclusion – Focus on Community Impact
Title: Metropolitan Experience - Phillip Levy, MD, MPH, FACC – Wayne State University
https://x.com/ACCinTouch/status/1712807931819806944?s=20
American College of Cardiology
@ACCinTouch
Moving beyond the "one patient, one provider" model of healthcare is needed to improve #CVD outcomes at the population level. Dr. Phillip Levy discusses community & institution perspectives needed to implement care pathways that will help shift the current paradigm. #ACCQuality23
Florida Lung Health Coalition Kickoff Symposium
“Applying Data Analytics to Mobile Healthcare”
June 2023; Tampa Bay, Florida
2023 Southern Emergency Medicine International Summit Forum
“Beyond Hypertensive Emergencies - Managing Patients
with Elevated BP in the ED”
April 2023; Guangzhou, China
National Arab American Medical Association 32nd International Medical Convention
“What’s Next for Population Health?”
December 2022; Marrakesh, Morocco
MedHealth Summit
“Democratizing Data for Healthcare Innovation and Action”
November 2022; Detroit, Michigan
2023 Investigator Skills Development Unit (ISDU) Webinars:
NOTE: Our Jan. 12th Webinar has been RESCHEDULED to July 19th due to illness. Thank you for your kind understanding.
- Fri., Feb. 24th, 11am PT (1p CT, 2p ET): Marilyn Thomas, PhD, MPH - Structural Racism and Health Disparities. Register HERE.
- Thurs., March 9th, 12pm PT (2p CT, 3p ET): Doriane Miller, MD Approaches to Community Engagement. Register HERE.
- Thurs., April 6th, 10am PT (12p CT, 1p ET): Ariel Deardorff, MLIS -- Get up to speed on the new NIH Data Management and Sharing Requirements. Register HERE.
- Wed., May 3rd, 10am PT (12p CT, 1p ET): Michael Potter, MD -- Practice-Based Research: A Focus on Community Primary Care Setting. Register HERE.
- Wed., June 7th, 11am PT (1p CT, 2p ET): Elaine Ku, MD, MAS -- Using Public Databases to Conduct Clinical Research: Focus on Hypertension. Register HERE.
- Wed., July 19th, 10am PT (12p CT, 1p ET): Damaris Javier, MA -- Navigating the NRMN Website and Resources for Early Career Investigators: MyNRMN, MyMentor, and more. Register HERE.
May-Dec. 2022 ISDU Webinars:
See our complete archive of Educational Webinars HERE!
- Thurs., May 12th 11am PDT: Orlando Gutiérrez, MD, MMSc -- Disparities in the Development and Progression of Kidney Disease in the U.S. Recording posted here.
- Thurs., June 16th 10am PDT: Edwin Charlebois, PhD, MPH -- Best Practices for Creating Poster Presentations for Scientific Conferences. Recording posted here.
- Thurs., July 21st 10am PDT: Daichi Shimbo, MD NIH K Award Info Session. Recording posted here.
- Fri., Aug. 19th, 11am PDT: Diana Redwood, PhD Addressing Health Disparities in Rural and Remote Areas: Improving Colorectal Cancer Screening among Alaska Native People. Recording posted here.
- Thurs. Sept. 22nd 11am: Rachel Shelton, ScD, MPH; Nathalie Moise, MD, MS -- Implementation Science Theories, Models, and Frameworks.Recording posted here.
- Thurs., Dec. 8th: Sara Landes, PhD -- Hybrid Effectiveness-Implementation Approaches. Recording posted here.
-
RESTORE Network Oversight Advisory Committee meeting in San Diego
RESTORE Network Team
Wayne State University: LEAP-HTN Team
AHA Hypertension Scientific Sessions (San Diego, CA)
Sept 8 (8:20-8:30): Neighborhood, Environment, and Hypertension
AHA Health Equity Research Network Meeting (San Diego, CA)
Sept 11 (12:15-1pm): Linkage, Empowerment, and Access to Prevent Hypertension (LEAP-HTN)
Community Engagement CORE: To provide training and infrastructure to establish community-academic partnerships and ensure meaningful community engagement across pilot and R01 projects. The focus is on communities in the Great Lakes regionDetroit and Cleveland.
Presentation Highlights
- Inclusive training programs with capacity-building curriculums for community members and early-stage investigators.
- ACHIEVE GREATER's official logo was designed in collaboration with community!